Back to Top
Brayton Purcell LLP
Call for A Free Consultation
Nationwide Service for over 30 years

Zofran Use May Increase Risk of Birth Defects

If you are in the first trimester of pregnancy and have been prescribed the drug Zofran to treat nausea and vomiting, your baby could be at risk for serious birth defects. This is because Zofran has not been approved for use in pregnant women.


Zofran has only been approved by the FDA to treat nausea and vomiting in patients who have undergone chemotherapy, radiotherapy, and surgery. Despite this, the maker of Zofran has encouraged doctors to prescribe the drug for off-label uses, such as morning sickness.

Several case studies have been done that have linked Zofran use with birth defects. These defects include mental problems, physical deformities, cardiac defects, and more. See our Zofran page to find out other ways infants have been affected be Zofran use during the first trimester.

The attorneys at Brayton Purcell LLP want to ensure that the maker and seller of Zofran is held accountable for failing to warn new mothers and families about the serious risks associated with taking the drug while pregnant. If you or someone you love has given birth to a baby with defects after taking Zofran during pregnancy, do not hesitate to contact our offices today.

No Comments

Leave a comment
Comment Information